Clinical Trial Update: 89Zr-Oxine-RY_SW01 Cell Injection for the Treatment of Systemic Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating 89Zr-Oxine-RY_SW01 cell injections for systemic sclerosis, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• 89Zr-Oxine-RY_SW01

Snippet

Sponsor: Jiangsu Renocell Biotech Company | Conditions: Systemic Sclerosis | Phase 1 | Status: NOT_YET_RECRUITING